Thrombosis associated with the use of recombinant activated factor VII: profiling two events

• References

• 1 Kenet G. et al. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999; 354: 1879.
• 2 Herbertson M. Recombinant activated factor VIIa in cardiac surgery. Blood Coagul Fibrinolysis 2004; 15 (Suppl): S31-2.
• 3 Silva MA. et al. The management of coagulopathy and blood loss in liver surgery. Semin Hematol 2004; 41: 132-9.
• 4 d’Oiron R. et al. Use of recombinant factor VIIa in 3 patients with inherited type 1 Glanzmann’s thrombasthenia undergoing invasive procedures. Thromb Haemost 2000; 83: 644-7.
• 5 Roberts HR. et al. Safety profile of recombinant factor VIIa. Semin Hematol 2004; 41: 101-8.
• 6 Dargaud Y. et al. Spontaneous proximal deep vein thrombosis in a patient with severe haemophilia A. Blood Coagul Fibrinolysis 2003; 14: 407-9.
• 7 Van der Planken MG. et al. Distal deep venous thrombosis in a haemophilia A patient with inhibitor and severe infectious disease, 18 days after recombinant activated factor VII transfusion. Blood Coagul Fibrinolysis 2002; 13: 367-70.
• 8 Aledort LM. Factor IX and thrombosis. Scand J Haematol 1977; 30: 40-2.
• 9 Keys NS. et al. Possible synergy between recombinant factor VIIa and prothrombin complex concentrate in hemophilia therapy. Thromb Haemost 2002; 88: 60-5.
• 10 Rosenfeld SB. et al. Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient. Thromb Haemost 2002; 87: 925.